Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study.

Autor: Kayser S; Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany; NCT Trial Center, National Center of Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg. s.kayser@dkfz-heidelberg.de., Kramer M; Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden., Martínez-Cuadrón D; Hematology Department, Hospital Universitari i Politècnic, La Fe, València, Spain; CIBERONC, Instituto Carlos III, Madrid., Grenet J; Division of Hematology and Oncology, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Metzeler KH; Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich., Sustkova Z; Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic., Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Brunner AM; Massachusetts General Hospital, Boston, MA., Elliott MA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Gil C; Hospital General, Alicante., Marini SC; Department of Clinical Haematology, Centro Hospitalar e Universitário de Coimbra, Coimbra., Ráčil Z; Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic; Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Cetkovsky P; Department of Internal Medicine and Haematology, 3rd Faculty of Medicine, Charles University and Faculty Hospital Kralovske Vinohrady, Charles University Prague, Czech Republic., Novak J; Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Perl AE; Division of Hematology and Oncology, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Platzbecker U; Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig., Stölzel F; Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden., Ho AD; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg., Thiede C; Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Röllig C; Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden., Montesinos P; Hematology Department, Hospital Universitari i Politècnic, La Fe, València, Spain; CIBERONC, Instituto Carlos III, Madrid., Schlenk RF; NCT Trial Center, National Center of Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany; Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg., Levis MJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.

Publikováno v: Haematologica [Haematologica] 2022 Apr 01; Vol. 107 (4), pp. 836-843. Date of Electronic Publication: 2022 Apr 01.

The induction of antibody reactivity to endogenous viral glycoprotein in 151(5) X 7(2) [chf(+), V(+)] chickens.

Autor: Marini SC, Mason WS, England JM, Halpern MS

Publikováno v: Virology [Virology] 1980 Jan 30; Vol. 100 (2), pp. 488-91.